NO974852L - Humant <beta>2-integrin-<alfa>-subenhet - Google Patents

Humant <beta>2-integrin-<alfa>-subenhet

Info

Publication number
NO974852L
NO974852L NO974852A NO974852A NO974852L NO 974852 L NO974852 L NO 974852L NO 974852 A NO974852 A NO 974852A NO 974852 A NO974852 A NO 974852A NO 974852 L NO974852 L NO 974852L
Authority
NO
Norway
Prior art keywords
integrin
beta
alfa
subunit
human
Prior art date
Application number
NO974852A
Other languages
English (en)
Other versions
NO318764B1 (no
NO974852D0 (no
Inventor
Michael W Gallatin
Monica Van Der Vieren
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Publication of NO974852D0 publication Critical patent/NO974852D0/no
Publication of NO974852L publication Critical patent/NO974852L/no
Publication of NO318764B1 publication Critical patent/NO318764B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19974852A 1996-02-22 1997-10-21 Humant <beta><N>2</N>-integrin-alfa-subenhet NO318764B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/605,672 US5817515A (en) 1993-12-23 1996-02-22 Human B2 integrin alpha subunit antibodies
PCT/US1997/002713 WO1997031099A1 (en) 1996-02-22 1997-02-24 Human beta 2 integrin alpha subunit

Publications (3)

Publication Number Publication Date
NO974852D0 NO974852D0 (no) 1997-10-21
NO974852L true NO974852L (no) 1997-12-19
NO318764B1 NO318764B1 (no) 2005-05-02

Family

ID=24424704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974852A NO318764B1 (no) 1996-02-22 1997-10-21 Humant <beta><N>2</N>-integrin-alfa-subenhet

Country Status (18)

Country Link
US (1) US5817515A (no)
EP (1) EP0835301B1 (no)
JP (1) JP2001526524A (no)
CN (1) CN1103812C (no)
AT (1) ATE293685T1 (no)
AU (1) AU723110B2 (no)
BR (1) BR9702101A (no)
CA (1) CA2218755C (no)
CZ (1) CZ287921B6 (no)
DE (1) DE69733051D1 (no)
FI (1) FI974018A (no)
HU (1) HU223977B1 (no)
IL (1) IL122011A (no)
NO (1) NO318764B1 (no)
PL (1) PL187013B1 (no)
RU (1) RU2183671C2 (no)
SK (1) SK283135B6 (no)
WO (1) WO1997031099A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837478A (en) * 1993-12-23 1998-11-17 Icos Corporation Method of identifying modulators of binding between and VCAM-1
US6620915B2 (en) * 1993-12-23 2003-09-16 Icos Corporation Monoclonal antibodies specific for integrin α-d subunit
US20030055231A1 (en) * 1998-10-28 2003-03-20 Jian Ni 12 human secreted proteins
WO2001070266A2 (en) 2000-03-17 2001-09-27 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
WO2023235971A1 (en) * 2022-06-08 2023-12-14 The Regents Of The University Of California Antibodies and immunotherapies that target the active conformation of integrin beta 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271139A (en) * 1978-03-27 1981-06-02 Hiram Hart Scintillation proximity assay
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
WO1992006697A1 (en) * 1990-10-23 1992-04-30 Repligen Corporation Anti-inflammatory composition
AU667487B2 (en) * 1991-10-01 1996-03-28 General Hospital Corporation, The Preventing allograft rejection with antibodies to adhesion molecules
DE69229275T2 (de) * 1991-10-04 1999-12-30 Us Health Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen
US5470953A (en) * 1993-12-23 1995-11-28 Icos Corporation Human β2 integrin α subunit
WO1995027736A1 (en) * 1994-04-12 1995-10-19 Boehringer Ingelheim Pharmaceuticals, Inc. Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection

Also Published As

Publication number Publication date
ATE293685T1 (de) 2005-05-15
CZ328697A3 (cs) 1998-07-15
AU723110B2 (en) 2000-08-17
NO318764B1 (no) 2005-05-02
JP2001526524A (ja) 2001-12-18
US5817515A (en) 1998-10-06
NO974852D0 (no) 1997-10-21
IL122011A (en) 2001-05-20
AU2133397A (en) 1997-09-10
SK283135B6 (sk) 2003-03-04
EP0835301B1 (en) 2005-04-20
HUP9901579A3 (en) 2001-10-29
CZ287921B6 (cs) 2001-03-14
HU223977B1 (hu) 2005-03-29
PL323195A1 (en) 1998-03-16
CN1103812C (zh) 2003-03-26
HUP9901579A2 (hu) 1999-08-30
PL187013B1 (pl) 2004-04-30
RU2183671C2 (ru) 2002-06-20
WO1997031099A1 (en) 1997-08-28
CN1189851A (zh) 1998-08-05
DE69733051D1 (de) 2005-05-25
IL122011A0 (en) 1998-03-10
EP0835301A1 (en) 1998-04-15
CA2218755C (en) 1999-08-31
BR9702101A (pt) 1999-07-20
CA2218755A1 (en) 1997-08-28
FI974018A0 (fi) 1997-10-21
FI974018A (fi) 1997-12-03
SK140997A3 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
ATE225670T1 (de) Antagonistische anti-avb3 integrin antikörper
EP0880597A4 (en) THERAPEUTIC APPLICATIONS FOR MONOCLONAL ANTIBODY 5c8 ANTI-T-BAM (ANTI-CD40-L)
HK1015282A1 (en) High affinity human monoclonal antibodies specificfor rsv f-protein.
MA21822A1 (fr) Composition de shampoing anti - pelicullaire .
NO924279D0 (no) Lyofilisert, monoklonalt antistoffpreparat
GEP20105118B (en) Anti-vegf antibodies
DE59813875D1 (de) Ko-stimulierendes polypeptid von t-zellen, monoklonale antikörper sowie die herstellung und deren verwendung
TR199500991A2 (tr) Glikoprotein hormon kuartet&#39;inin tek-zincirli sekilleri.
DE69111930D1 (de) Künstlicher Antikörper.
ITRM920457A0 (it) Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteinaumana.
DE59603694D1 (de) Endoprothese, insbesondere für das Sternum-Clavicular-Gelenk
IL139852A0 (en) Monoclonal antibodies directed against the g3bp protein, and uses
NO974852L (no) Humant &lt;beta&gt;2-integrin-&lt;alfa&gt;-subenhet
TR199501542A2 (tr) Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
FR2712467B3 (fr) Structure pour branche de parapluie.
DE3886545D1 (de) Monoklonale human-antikörper, spezifisch für rh(d).
DE69129582D1 (de) Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay
DE3851855D1 (de) Gegen die Gamma-Kette des T-Zell-Rezeptors gerichteter monoklonaler Antikörper.
EP0640621A3 (en) Monoclonal anti-thrombin antibody.
DK31589A (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
EP0654532A4 (en) ANTIMUCOGLYCOPROTEIN MONOCLONAL ANTIBODIES.
EP0538267A4 (en) Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same